Subscribe To
Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD
– Successful Completion of Recruitment Driven by Strong Clinical Site Participation and Investigator Support – – Topline Data Expected in Q3 2024 – ALPHARETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced […] The post Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD app...
Read More
Posted: Nov 1 2023, 11:05
Author Name: forextv
Views: 112158